Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Francisco Vera-Badillo"'
Autor:
Melissa Chan, Martin C Chang, Rosa González, Belinda Lategan, Elvira del Barco, Francisco Vera-Badillo, Paula Quesada, Robyn Goldstein, Ignacio Cruz, Alberto Ocana, Juan J Cruz, Eitan Amir
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0132449 (2015)
To describe the clinical features and outcomes of estrogen receptor negative (ER-) and progesterone receptor positive (PgR+) breast cancer.We retrospectively reviewed a well-characterized database of sequential patients diagnosed with early stage inv
Externí odkaz:
https://doaj.org/article/5e1daa22af19464aa68322d59ea3a4cf
Autor:
Alberto Ocana, Francisco Vera-Badillo, Mustafa Al-Mubarak, Arnoud J Templeton, Verónica Corrales-Sanchez, Laura Diez-Gonzalez, María D Cuenca-Lopez, Bostjan Seruga, Atanasio Pandiella, Eitan Amir
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e95219 (2014)
Aberrations in the phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR)/AKT pathway are common in solid tumors. Numerous drugs have been developed to target different components of this pathway. However the prognostic value of th
Externí odkaz:
https://doaj.org/article/3cf8708db7b24791ac7ac6dcb8625b8e
Autor:
Christopher J Sweeney, Andrew J Martin, Martin R Stockler, Stephen Begbie, Leanna Cheung, Kim N Chi, Simon Chowdhury, Mark Frydenberg, Lisa G Horvath, Anthony M Joshua, Nicola J Lawrence, Gavin Marx, John McCaffrey, Ray McDermott, Margaret McJannett, Scott A North, Francis Parnis, Wendy Parulekar, David W Pook, Martin Neil Reaume, Shahneen K Sandhu, Alvin Tan, Thean Hsiang Tan, Alastair Thomson, Francisco Vera-Badillo, Scott G Williams, Diana Winter, Sonia Yip, Alison Y Zhang, Robert R Zielinski, Ian D Davis, Ehtesham Abdi, Suzanne Allan, Patricia Bastick, Robert Blum, Karen Briscoe, Daniel Brungs, Sean Bydder, Bala Renuka Chittajallu, Michelle Cronk, Katharine Cuff, Anthony Dowling, Matthew George, Lisa Horvath, Elizabeth Hovey, Anthony Joshua, Narayan Karanth, Ganessan Kichenadasse, Laurence Krieger, Maitham Mathlum, Louise Nott, Zulfiquer Otty, David Pook, Shahneen Sandhu, Sanjeev Sewak, Amanda Stevanovic, Martin Stockler, Aneta Suder, Hsiang Tan, Javier Torres, Simon Troon, Craig Underhill, Andrew Weickhardt, Robert Zielinski, Tahir Abbas, Ghadeer Anan, Chris Booth, Holly Campbell, Kim Chi, Joseph Chin, Edmond Chouinard, Bryan Donnelly, Darrel Drachenberg, Amir Faghih, Antonio Finelli, Sebastien Hotte, Krista Noonan, Scott North, Mohammad Rassouli, Neil Reaume, Ricardo Rendon, Fred Saad, Evgeny Sadikov, Eric Vigneault, Pawel Zalewski, Patrick Morris, Miriam O'Connor, Paul Donnellan, Dearbhaile O'Donnell, Jim Edwards, Peter Fong, Simon Crabb, Omar Khan, Vincent Khoo, Graham Macdonald, Heather Payne, Angus Robinson, Jonathon Shamash, John Staffurth, Carys Thomas
Publikováno v:
The Lancet Oncology. 24:323-334
Autor:
Eitan Amir, Atanasio Pandiella, Fernando Andrés-Pretel, Bostjan Seruga, Verónica Corrales-Sánchez, Gemma Serrano-Heras, María José Escribano, Francisco Vera-Badillo, Arnoud J. Templeton, Dolores C. García-Olmo, Laura Díez-González, Alberto Ocaña
Supplementary Figure 1: Forest plot showing the pooled odds ratio (OR) for overall survival at 1 year for circulating tumor DNA. Supplementary Figure 2: Forest plot showing the pooled odds ratio (OR) for overall survival at 1 year for total circulati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c9354534acd8ca499c6b159f751e952
https://doi.org/10.1158/1055-9965.22438683.v1
https://doi.org/10.1158/1055-9965.22438683.v1
Autor:
Eitan Amir, Atanasio Pandiella, Fernando Andrés-Pretel, Bostjan Seruga, Verónica Corrales-Sánchez, Gemma Serrano-Heras, María José Escribano, Francisco Vera-Badillo, Arnoud J. Templeton, Dolores C. García-Olmo, Laura Díez-González, Alberto Ocaña
Detailed description of the included studies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcf363e9e9fbfbe47ee2719ce1c6888b
https://doi.org/10.1158/1055-9965.22438680
https://doi.org/10.1158/1055-9965.22438680
Autor:
Eitan Amir, Atanasio Pandiella, Fernando Andrés-Pretel, Bostjan Seruga, Verónica Corrales-Sánchez, Gemma Serrano-Heras, María José Escribano, Francisco Vera-Badillo, Arnoud J. Templeton, Dolores C. García-Olmo, Laura Díez-González, Alberto Ocaña
Background: The ability to undertake molecular analysis to inform on prognosis and predictors of response to therapy is limited by accessibility of tissue. Measurement of total circulating free DNA (cfDNA) or circulating tumor DNA (ctDNA) in peripher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61be718e558063d3ed607262d0b6128c
https://doi.org/10.1158/1055-9965.c.6516480.v1
https://doi.org/10.1158/1055-9965.c.6516480.v1
Autor:
Martin R, Stockler, Andrew J, Martin, Ian D, Davis, Haryana M, Dhillon, Stephen D, Begbie, Kim N, Chi, Simon, Chowdhury, Xanthi, Coskinas, Mark, Frydenberg, Wendy E, Hague, Lisa G, Horvath, Anthony M, Joshua, Nicola J, Lawrence, Gavin M, Marx, John, McCaffrey, Ray, McDermott, Margaret, McJannett, Scott A, North, Francis, Parnis, Wendy R, Parulekar, David W, Pook, M Neil, Reaume, Shahneen, Sandhu, Alvin, Tan, Thean Hsiang, Tan, Alastair, Thomson, Francisco, Vera-Badillo, Scott G, Williams, Diana G, Winter, Sonia, Yip, Alison Y, Zhang, Robert R, Zielinski, Christopher J, Sweeney
Publikováno v:
Journal of Clinical Oncology. 40:837-846
PURPOSE We previously reported that enzalutamide improved overall survival when added to standard of care in metastatic, hormone-sensitive prostate cancer. Here, we report its effects on aspects of health-related quality of life (HRQL). METHODS HRQL
Publikováno v:
Journal of Urology. 203
Publikováno v:
Journal of the National Cancer Institute. 107(10)
Autor:
Boutron I; Isabelle Boutron, Sally Hopewell, and Philippe Ravaud, Methods of Therapeutic Evaluation of Chronic Diseases Team, Epidemiology and Biostatistics Sorbonne Paris Cité Research Centre, Unite Mixte de Recherche 1153, L'Institut National de la Santé et de la Recherche Médicale; Isabelle Boutron and Philippe Ravaud, Assistance Publique des Hôpitaux de Paris, Hôpital Hôtel Dieu; Isabelle Boutron and Philippe Ravaud, Paris Descartes University, Sorbonne Paris Cité; Isabelle Boutron, Sally Hopewell, and Philippe Ravaud, French Cochrane Centre, Paris, France; Douglas G. Altman and Sally Hopewell, Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom; Francisco Vera-Badillo and Ian Tannock, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Philippe Ravaud, Columbia University Mailman School of Public Health, New York, NY. isabelle.boutron@htd.aphp.fr., Altman DG; Isabelle Boutron, Sally Hopewell, and Philippe Ravaud, Methods of Therapeutic Evaluation of Chronic Diseases Team, Epidemiology and Biostatistics Sorbonne Paris Cité Research Centre, Unite Mixte de Recherche 1153, L'Institut National de la Santé et de la Recherche Médicale; Isabelle Boutron and Philippe Ravaud, Assistance Publique des Hôpitaux de Paris, Hôpital Hôtel Dieu; Isabelle Boutron and Philippe Ravaud, Paris Descartes University, Sorbonne Paris Cité; Isabelle Boutron, Sally Hopewell, and Philippe Ravaud, French Cochrane Centre, Paris, France; Douglas G. Altman and Sally Hopewell, Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom; Francisco Vera-Badillo and Ian Tannock, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Philippe Ravaud, Columbia University Mailman School of Public Health, New York, NY., Hopewell S; Isabelle Boutron, Sally Hopewell, and Philippe Ravaud, Methods of Therapeutic Evaluation of Chronic Diseases Team, Epidemiology and Biostatistics Sorbonne Paris Cité Research Centre, Unite Mixte de Recherche 1153, L'Institut National de la Santé et de la Recherche Médicale; Isabelle Boutron and Philippe Ravaud, Assistance Publique des Hôpitaux de Paris, Hôpital Hôtel Dieu; Isabelle Boutron and Philippe Ravaud, Paris Descartes University, Sorbonne Paris Cité; Isabelle Boutron, Sally Hopewell, and Philippe Ravaud, French Cochrane Centre, Paris, France; Douglas G. Altman and Sally Hopewell, Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom; Francisco Vera-Badillo and Ian Tannock, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Philippe Ravaud, Columbia University Mailman School of Public Health, New York, NY., Vera-Badillo F; Isabelle Boutron, Sally Hopewell, and Philippe Ravaud, Methods of Therapeutic Evaluation of Chronic Diseases Team, Epidemiology and Biostatistics Sorbonne Paris Cité Research Centre, Unite Mixte de Recherche 1153, L'Institut National de la Santé et de la Recherche Médicale; Isabelle Boutron and Philippe Ravaud, Assistance Publique des Hôpitaux de Paris, Hôpital Hôtel Dieu; Isabelle Boutron and Philippe Ravaud, Paris Descartes University, Sorbonne Paris Cité; Isabelle Boutron, Sally Hopewell, and Philippe Ravaud, French Cochrane Centre, Paris, France; Douglas G. Altman and Sally Hopewell, Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom; Francisco Vera-Badillo and Ian Tannock, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Philippe Ravaud, Columbia University Mailman School of Public Health, New York, NY., Tannock I; Isabelle Boutron, Sally Hopewell, and Philippe Ravaud, Methods of Therapeutic Evaluation of Chronic Diseases Team, Epidemiology and Biostatistics Sorbonne Paris Cité Research Centre, Unite Mixte de Recherche 1153, L'Institut National de la Santé et de la Recherche Médicale; Isabelle Boutron and Philippe Ravaud, Assistance Publique des Hôpitaux de Paris, Hôpital Hôtel Dieu; Isabelle Boutron and Philippe Ravaud, Paris Descartes University, Sorbonne Paris Cité; Isabelle Boutron, Sally Hopewell, and Philippe Ravaud, French Cochrane Centre, Paris, France; Douglas G. Altman and Sally Hopewell, Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom; Francisco Vera-Badillo and Ian Tannock, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Philippe Ravaud, Columbia University Mailman School of Public Health, New York, NY., Ravaud P; Isabelle Boutron, Sally Hopewell, and Philippe Ravaud, Methods of Therapeutic Evaluation of Chronic Diseases Team, Epidemiology and Biostatistics Sorbonne Paris Cité Research Centre, Unite Mixte de Recherche 1153, L'Institut National de la Santé et de la Recherche Médicale; Isabelle Boutron and Philippe Ravaud, Assistance Publique des Hôpitaux de Paris, Hôpital Hôtel Dieu; Isabelle Boutron and Philippe Ravaud, Paris Descartes University, Sorbonne Paris Cité; Isabelle Boutron, Sally Hopewell, and Philippe Ravaud, French Cochrane Centre, Paris, France; Douglas G. Altman and Sally Hopewell, Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom; Francisco Vera-Badillo and Ian Tannock, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Philippe Ravaud, Columbia University Mailman School of Public Health, New York, NY.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2014 Dec 20; Vol. 32 (36), pp. 4120-6. Date of Electronic Publication: 2014 Nov 17.